Navigation Links
GENova Biotherapeutics secures new cancer drugs targets
Date:9/17/2009

NEW YORK, Sept. 17 /PRNewswire-FirstCall/ - (OTCBB: GVBP.OB) - GENova Biotherapeutics Inc. ("GENova"), a biotechnology company that develops novel therapeutic proteins that disrupt the advance of life-threatening cancers, today announced it has signed a collaboration deal with Beckpharma Ltd. ("Beckpharma") -a pharmaceutical development company also involved in cancer treatments.

The two companies are joining forces in their mutual mission to identify, acquire, and out-license promising cancer drugs in an effort that will not only save millions on GENova's R D budget, but at the same time will significant increase GENova's distribution, the deal with Beckpharma is the latest deal in a string of deals that GENova has recently done in a continued effort to increase its IP portfolio and increase its distribution network.

"By combining our efforts with Beckpharma's, we are casting a wider net when it comes to sourcing new cancer drug targets. Beckpharma has close relationships with academic research institutions around the world, and now, through this collaboration, their industry contacts become ours, and vice versa," says Aaron Whiteman, CEO for GENova.

This collaboration will bolster GENova's acquisition activities and funnel more promising drug targets into its drug development pipeline. GENova will also leverage the scientific expertise of Beckpharma's Research and Development Team, as well as its established distribution channels with Big Pharmaceutical companies.

Furthermore, scientists in both GENova and Beckpharma are examining their current IP portfolios to gain insight into possible synergies between their drug targets, and the possibility of making a stronger, better, combined product by coordinating their biotechnologies.

"This is a positive step for GENova," says Whiteman. "Through our collaboration with Beckpharma we are gaining access to their technologies and relationships, and we hope to leverage that to b
'/>"/>

SOURCE GENova Biotherapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. GENova Biotherapeutics signs engagement agreement with PacificWave Partners Limited
2. GENova and TheraGlass in advanced negotiations
3. GENova Biotherapeutics forming academic partnerships
4. GENova Biotherapeutics signs collaboration agreement with Prime BioResearch
5. GENova Biotherapeutics and Prime BioResearch signs LOI on diabetes and cancer cure
6. GENova gains access to Big Pharma
7. GENova appoints Dr. Wang Chong to Scientific Advisory Board
8. GENova appoints Dr. Philip Gould to Scientific Advisory Board
9. GENova issues clarifying press release
10. GENova to acquire three new drug target patents worth in excess of $1 billion in royalty fees
11. GENova files patent for new breast cancer treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... ... July 31, 2015 , ... Ticket Down is a reliable source ... in Chicago at Grant Park. The festival will end on Sunday, August 2nd. ... Chicago for the annual Lollapalooza. This unique and unbelievably popular festival attracts the ...
(Date:7/31/2015)... ... July 31, 2015 , ... Recently touted by ... predictive health analytics , Jvion continues to disrupt the predictive analytic and ... that targets patient and population level illness to drive prevention and better health ...
(Date:7/31/2015)... Tenn. (PRWEB) , ... July 31, 2015 , ... The ... Robert Church Park in Downtown Memphis on October 3, 2015. The Ride to Fight ... focused on cancer research between Methodist Healthcare, The West Clinic and The University of ...
(Date:7/31/2015)... ... July 31, 2015 , ... There’s no better way to enjoy the summer ... to cook the next meal, making July the most appropriate to be National Hot ... and recipes. , Make the next cookout different than the ones in the past. ...
(Date:7/31/2015)... ... July 31, 2015 , ... Facebook, Twitter, Linkedin and blogs ... social media profiles to better connect with the public. The agency website at ... share insights and opinions. The Rally Insurance Group, Inc.’s pledge to provide effortless ...
Breaking Medicine News(10 mins):Health News:Cheap 2015 Lollapalooza Tickets: Ticket Down Slashes Ticket Prices on Lollapalooza Tickets at Grant Park in Chicago for Saturday, August 1st and Sunday, August 2nd 2Health News:Jvion Showcased as Leader in the Predictive Analytic Market 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 3Health News:King Kullen Honors National Hot Dog and Blueberry Month 2Health News:King Kullen Honors National Hot Dog and Blueberry Month 3Health News:Rally Insurance Group, Inc. Connects to Customers Through Re-branded Social Media Profiles 2
... the late 1990s, deep brain stimulation (DBS) has proven ... Parkinson,s disease, a cruel neurological disorder that can cause ... and rigidity, among other symptoms. The ... be adequately controlled with medications. A neurosurgeon uses magnetic ...
... sexual function that leave them feeling guilty and a ... Congress of the European Society for Medical Oncology (ESMO) ... and fertility concerns are often not adequately addressed by ... Centre in Adelaide said that fertility concerns among cancer ...
... Overhage, M.D., Ph.D., a national leader in the development ... exchange, has been elected to the prestigious Institute of ... Dr. Overhage is at the forefront of policy, standards, ... of medical data to improve patient care delivery and ...
... the subject of many studies since its discovery in ... of XMRV,s role in human disease. In three recent ... Journal of Infectious Diseases , now available online, ... prostate cancer but not other links involving chronic fatigue ...
... TUESDAY, Oct. 12 (HealthDay News) -- The so-called racial gap ... with black and Hispanic women less likely to get ... known is what the issue is -- is it race ... a medical oncologist at Dana Farber Cancer Institute in Boston, ...
... 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium will ... which will be held Dec. 8-12 in the Henry ... M.D., Ph.D., is the recipient of the 2010 AACR ... Susan G. Komen for the Cure. Alan Ashworth, Ph.D., ...
Cached Medicine News:Health News:Researchers reach consensus on use of deep brain stimulation to treat Parkinson's 2Health News:Fertility concerns of cancer survivors inadequately addressed, study finds 2Health News:Fertility concerns of cancer survivors inadequately addressed, study finds 3Health News:J. Marc Overhage elected to Institute of Medicine 2Health News:New studies examine links between XMRV and human disease 2Health News:New studies examine links between XMRV and human disease 3Health News:Insurance, Income Don't Explain 'Race Gap' in Breast Cancer Care 2Health News:Insurance, Income Don't Explain 'Race Gap' in Breast Cancer Care 3Health News:AACR to honor leading researchers at breast cancer symposium 2
(Date:7/30/2015)... , July 30, 2015  EP Global Communications, ... have recently contacted the Company about discussing EPGL,s ... early as Monday, August 3, 2015.  Novartis CEO ... saying that the coming electronic contact lens market ... over the next several years.  Novartis partnered with ...
(Date:7/30/2015)... and VANCOUVER , July 30, ... announced today that it will report its second quarter ... management will host a conference call and live webcast ... of financial results, clinical development programs and a general ... log on to the Investor Relations page of the ...
(Date:7/30/2015)... THOUSAND OAKS, Calif. , July 30, 2015  Amgen ... Fred Hassan , partner and managing director of Warburg Pincus ... "We are pleased to welcome Fred Hassan and ... to the Amgen Board," said Robert A. Bradway , ... expertise and commitment to innovation will serve Amgen well." ...
Breaking Medicine Technology:Amgen Announces Appointment Of Fred Hassan To Board Of Directors 2Amgen Announces Appointment Of Fred Hassan To Board Of Directors 3
...  American HealthTech ( www.healthtech.net ), the Ultimate Connectivity ... Wound Management to Quality Assurance.  In a single ... Braden assessment wizard to enhance quality care planning ... added to Outcomes Reporting for providers wanting to ...
... Feb. 23, 2012 Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ... to present at the Citi 2012 Global Health Care Conference ... (10:30 a.m. Pacific Time) at the Waldorf=Astoria in New York ... scheduled to provide a corporate overview. A live ...
Cached Medicine Technology:American HealthTech Announces Comprehensive Wound Management 2Arena Pharmaceuticals to Present at the Citi 2012 Global Health Care Conference 2Arena Pharmaceuticals to Present at the Citi 2012 Global Health Care Conference 3
... unique fiberoptic laryngoscope blade that can give ... needed during difficult intubations. The articulating tip ... to be raised by squeezing a lever ... produces a more complete exposure of the ...
... laryngoscope handles can be used with Portex® ... sturdy chrome blades with long-lasting bronze fiber-optic ... for continuous routine use., ,The laryngoscope ... of sizes, from infant to large adult, ...
... handles can be used with Portex® reusable ... chrome blades with long-lasting bronze fiber-optic bundles ... continuous routine use., ,The laryngoscope blades ... sizes, from infant to large adult, and ...
... an innovative intubation system. Providing an unobstructed ... is ideal for many types of intubations., ... embedded within the patented Glidescope blade. Clear ... displayed on a monitor screen. An LED ...
Medicine Products: